Back

Effect of neprilysin inhibitor for ischemic mitral regurgitation after myocardial injury

3 September 2019 (15:45 - 16:35)
Organised by:
Congress Presentation Part of: Basic mechanism of valvular heart disease Valvular Heart Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Miss Naaleum Song

Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Novel model of intensity graded murine wire-induced aortic valve stenosis mimics distinct stages of human aortic valve pathology
Doctor S. Niepmann (Bonn, DE)
Abstract Slides
Presentation thumbnail
Non-classical Ly6C-low monocytes contribute to aortic valve stenosis development in mice
Doctor S. Niepmann (Bonn, DE)
Abstract Slides
Presentation thumbnail
In vivo tracking of long-term survival of xenogeneic porcine mesenchymal stem cells seeded on tissue-engineered heart valve implanted in sheep
Doctor K. Zlabinger (Vienna, AT)
Abstract
Presentation thumbnail
Cellular mechanisms of aortic valve calcification in primary human valvular interstitial cell culture
Doctor E. Zhiduleva (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Why aortic valve disease may persist after surgery? A joint basic science - Clinical effort
Doctor J. Petersen (Hamburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Basic mechanism of valvular heart disease

The Event

Event poster

ESC Congress 2019

3 September 2019 15:45 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure and valvular heart disease
thumbnail
Congress Session
How to manage valvular heart disease in heart failure
thumbnail
Congress Session
Failing valves and beyond

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources